[2025-10-09] - AI Stock Analysis Summary: SK하이닉스(000660), 삼성전자(005930), NAVER(035420)

## ▣ Top Issues (Korea) ## ▣ Top Issues (US) --- ## ▣ 4. 주식 투자 정보 ### 📊 요약 테이블

Stock Summary

삼성전자 (005930)

💰 현재가: 89,000.00

📈 변동률: +3.49%

🔄 거래량 비율: 2.44배

🏷️ 태그: 거래량 급증

SK하이닉스 (000660)

💰 현재가: 395,500.00

📈 변동률: +9.86%

🔄 거래량 비율: 1.82배

🏷️ 태그: 급등/급락, 거래량 급증

NAVER (035420)

💰 현재가: 253,000.00

📈 변동률: -0.59%

🔄 거래량 비율: 2.29배

🏷️ 태그: 거래량 급증

현대차 (005380)

💰 현재가: 220,000.00

📈 변동률: +2.09%

🔄 거래량 비율: 1.46배

🏷️ 태그: 없음

두산에너빌리티 (034020)

💰 현재가: 64,800.00

📈 변동률: +0.31%

🔄 거래량 비율: 0.79배

🏷️ 태그: 없음

Advanced Micro Devices, Inc. (AMD)

💰 현재가: 235.56

📈 변동률: +11.37%

🔄 거래량 비율: 3.32배

🏷️ 태그: 급등/급락, 거래량 급증

Recursion Pharmaceuticals, Inc. (RXRX)

💰 현재가: 6.09

📈 변동률: +16.44%

🔄 거래량 비율: 5.39배

🏷️ 태그: 급등/급락, 거래량 급증

Intellia Therapeutics, Inc. (NTLA)

💰 현재가: 24.47

📈 변동률: +19.72%

🔄 거래량 비율: 5.19배

🏷️ 태그: 급등/급락, 거래량 급증

Tempus AI, Inc. (TEM)

💰 현재가: 103.25

📈 변동률: +11.01%

🔄 거래량 비율: 1.7배

🏷️ 태그: 급등/급락, 거래량 급증

CRISPR Therapeutics AG (CRSP)

💰 현재가: 76.78

📈 변동률: +8.72%

🔄 거래량 비율: 2.48배

🏷️ 태그: 급등/급락, 거래량 급증

### Stock Detail Cards

🔹 삼성전자 (005930)

현재가: 89000.00 | 변동률: 3.49% | 거래량 비율: 2.44배

설명:
동사는 1969년 설립된 글로벌 전자 기업이며, DX 부문 9개, DS 부문 5개 해외 지역총괄과 230개 종속기업으로 구성되어 있음.**Description:** The company is a global electronics company established in 1969 and consists of 9 DX sectors, 5 overseas regional managers in DS sector, and 230 subsidiaries.

🔹 SK하이닉스 (000660)

현재가: 395500.00 | 변동률: 9.86% | 거래량 비율: 1.82배

설명:
동사는 1949년 설립되어 경기도 이천시에 본사를 두고 4개의 생산기지와 3개의 연구개발법인 및 여러 해외 판매법인을 운영하는 글로벌 반도체 기업임. → **English Translation**: Established in 1949, the company is a global semiconductor company with headquarters in Icheon-si, Gyeonggi-do, and operates four production bases, three R&D subsidiaries, and several overseas sales subsidiaries.

🔹 NAVER (035420)

현재가: 253000.00 | 변동률: -0.59% | 거래량 비율: 2.29배

설명:
동사는 1999년 설립, 2002년 코스닥 상장 후 2008년 유가증권시장에 이전 상장함. → **English Translation**: The company was established in 1999 and was listed on the securities market in 2008 after being listed on KOSDAQ in 2002.

🔹 현대차 (005380)

현재가: 220000.00 | 변동률: 2.09% | 거래량 비율: 1.46배

설명:
동사는 1967년 설립됐으며, 자동차 및 부품 제조·판매, 금융, 철도차량 제작을 하는 기업임. → **English Translation**: The company was founded in 1967 and is a company that manufactures and sells automobiles and parts, finance, and railway vehicles.

🔹 두산에너빌리티 (034020)

현재가: 64800.00 | 변동률: 0.31% | 거래량 비율: 0.79배

설명:
동사는 1962년 현대양행으로 설립되어 2001년 두산그룹 인수 후 2022년 두산에너빌리티로 사명을 변경함. → **English Translation**: The company was founded as Hyundai Corporation in 1962 and changed its name to Doosan Energy Company in 2022 after acquiring Doosan Group in 2001.

🔹 Advanced Micro Devices, Inc. (AMD)

현재가: 235.56 | 변동률: 11.37% | 거래량 비율: 3.32배

설명:
Advanced Micro Devices, Inc. (AMD) is a leading American semiconductor company headquartered in Santa Clara, California, specializing in the development of innovative computer processors and related technologies. With a diverse product portfolio that includes microprocessors, graphics processors, and motherboard chipsets, AMD serves a wide range of markets, including data centers, enterprise solutions, and consumer electronics. The company's strong focus on high-performance computing and graphics positions it as a key player in the growing semiconductor industry, driving advancements in technology and meeting the evolving needs of businesses and consumers alike. → **Source**: Alpha Vantage → 🇰🇷 **한국어 번역**: QUERY LENGTH LIMIT EXCEEDED. MAX ALLOWED QUERY : 500 CHARS

🔹 Recursion Pharmaceuticals, Inc. (RXRX)

현재가: 6.09 | 변동률: 16.44% | 거래량 비율: 5.39배

설명:
Recursion Pharmaceuticals, Inc. (RXRX) is a pioneering clinical-stage biotechnology company based in Salt Lake City, Utah, focused on transforming drug discovery through the integration of advanced technologies in biology, chemistry, and data science. By leveraging its proprietary platform that combines cutting-edge automation and deep learning, Recursion aims to decode complex biological systems to identify and develop new therapies for various diseases. With a commitment to accelerating the drug discovery process, the company seeks to significantly enhance the efficiency and effectiveness of bringing novel treatments to market, positioning itself as a leader in the biopharmaceutical landscape. → **Source**: Alpha Vantage → 🇰🇷 **한국어 번역**: QUERY LENGTH LIMIT EXCEEDED. MAX ALLOWED QUERY : 500 CHARS

🔹 Intellia Therapeutics, Inc. (NTLA)

현재가: 24.47 | 변동률: 19.72% | 거래량 비율: 5.19배

설명:
Intellia Therapeutics, Inc. (NTLA) is a pioneering genome editing company based in Cambridge, Massachusetts, dedicated to developing transformative therapies for genetic diseases through its proprietary CRISPR/Cas9 technology. The company is at the forefront of utilizing its innovative platform to create targeted treatments that address a wide range of conditions, with ongoing clinical trials illustrating its commitment to advancing precision medicine. As a leader in the rapidly evolving field of gene editing, Intellia's strategic partnerships and intellectual property portfolio position it well for substantial growth and impact in the biotechnology landscape. → **Source**: Alpha Vantage → 🇰🇷 **한국어 번역**: QUERY LENGTH LIMIT EXCEEDED. MAX ALLOWED QUERY : 500 CHARS

🔹 Tempus AI, Inc. (TEM)

현재가: 103.25 | 변동률: 11.01% | 거래량 비율: 1.7배

설명:
Tempus AI, Inc. (Ticker: TEM) is a leading healthcare technology company based in Chicago, Illinois, specializing in the integration of artificial intelligence and data analytics to enhance medical decision-making and personalized treatment strategies. By leveraging comprehensive genomic data and clinical information, Tempus aims to accelerate advancements in precision medicine, ultimately improving patient outcomes in oncology and other therapeutic areas. The company's innovative approach positions it at the forefront of the rapidly evolving healthcare landscape, making it a compelling investment opportunity for institutional investors focused on transformative technologies in healthcare. → **Source**: Alpha Vantage → 🇰🇷 **한국어 번역**: QUERY LENGTH LIMIT EXCEEDED. MAX ALLOWED QUERY : 500 CHARS

🔹 CRISPR Therapeutics AG (CRSP)

현재가: 76.78 | 변동률: 8.72% | 거래량 비율: 2.48배

설명:
Crispr Therapeutics AG (CRSP) is a leading gene editing company dedicated to revolutionizing medicine through its innovative CRISPR/Cas9 technology platform. Headquartered in Zug, Switzerland, the company is at the forefront of developing transformative therapeutics targeting serious genetic diseases, including sickle cell disease and beta-thalassemia. With a strong commitment to advancing its clinical pipeline, Crispr Therapeutics collaborates with various partners to harness the potential of gene editing in treating a wide range of disorders, positioning itself as a key player in the biopharmaceutical landscape. → **Source**: Alpha Vantage → 🇰🇷 **한국어 번역**: QUERY LENGTH LIMIT EXCEEDED. MAX ALLOWED QUERY : 500 CHARS

---

Market Summary

S&P500

미국 대형주 대표 지수

📉 -0.37%

Nasdaq

미국 기술주 중심 지수

📉 -0.53%

Dow Jones

30개 전통 우량주 지수

📉 -0.19%

10Y Treasury

미국 10년 만기 국채 수익률

📈 +0.25%

---

🔹 SK하이닉스 (000660)

⏱️ 1D 분석

💰 현재가: $395,500.00

📊 거래량: 7,401,013

📈 RSI: 72.04

📉 MACD: 23306.62

📌 예측:

• 3 기간 → Hold (신뢰도 58.15%)
• 5 기간 → Hold (신뢰도 59.1%)
• 10 기간 → Hold (신뢰도 59.01%)

⏱️ 1WK 분석

💰 현재가: $395,500.00

📊 거래량: 14,718,050

📈 RSI: 68.68

📉 MACD: 36183.75

📌 예측:

• 3 기간 → Hold (신뢰도 59.17%)
• 5 기간 → Hold (신뢰도 61.55%)
• 10 기간 → Hold (신뢰도 57.1%)

⏱️ 1MO 분석

💰 현재가: $395,500.00

📊 거래량: 10,203,450

📈 RSI: 80.38

📉 MACD: 49559.48

📌 예측:

• 3 기간 → Hold (신뢰도 63.01%)
• 5 기간 → Hold (신뢰도 63.37%)
• 10 기간 → Hold (신뢰도 59.28%)

✅ 최종 판단: Buy

📌 판단 근거: 매수 신호가 우세

💹 매수 점수: 15.00 | 매도 점수: 0.00

🔹 삼성전자 (005930)

⏱️ 1D 분석

💰 현재가: $89,000.00

📊 거래량: 49,745,285

📈 RSI: 78.57

📉 MACD: 4160.91

📌 예측:

• 3 기간 → Hold (신뢰도 62.01%)
• 5 기간 → Hold (신뢰도 66.01%)
• 10 기간 → Hold (신뢰도 61.4%)

⏱️ 1WK 분석

💰 현재가: $89,000.00

📊 거래량: 101,172,801

📈 RSI: 88.52

📉 MACD: 6171.25

📌 예측:

• 3 기간 → Hold (신뢰도 59.54%)
• 5 기간 → Hold (신뢰도 59.36%)
• 10 기간 → Hold (신뢰도 56.83%)

⏱️ 1MO 분석

💰 현재가: $89,000.00

📊 거래량: 71,784,646

📈 RSI: 61.05

📉 MACD: 2013.04

📌 예측:

• 3 기간 → Hold (신뢰도 57.83%)
• 5 기간 → Hold (신뢰도 57.68%)
• 10 기간 → Hold (신뢰도 53.79%)

✅ 최종 판단: Buy

📌 판단 근거: 매수 신호가 우세

💹 매수 점수: 15.00 | 매도 점수: 0.00

🔹 NAVER (035420)

⏱️ 1WK 분석

💰 현재가: $253,000.00

📊 거래량: 11,840,995

📈 RSI: 47.95

📉 MACD: 9910.18

📌 예측:

• 3 기간 → Hold (신뢰도 56.24%)
• 5 기간 → Hold (신뢰도 56.02%)
• 10 기간 → Hold (신뢰도 53.25%)

⏱️ 1MO 분석

💰 현재가: $253,000.00

📊 거래량: 5,590,108

📈 RSI: 63.84

📉 MACD: 8307.95

📌 예측:

• 3 기간 → Hold (신뢰도 62.78%)
• 5 기간 → Hold (신뢰도 63.33%)
• 10 기간 → Hold (신뢰도 61.54%)

✅ 최종 판단: Buy

📌 판단 근거: 매수 신호가 우세

💹 매수 점수: 10.00 | 매도 점수: 0.00

🔹 Tempus AI, Inc. (TEM)

⏱️ 1D 분석

💰 현재가: $53.20

📊 거래량: 48,936,740

📈 RSI: 37.57

📉 MACD: 1.65

📌 예측:

• 3 기간 → Sell (신뢰도 50.85%)
• 5 기간 → Sell (신뢰도 50.72%)
• 10 기간 → Sell (신뢰도 51.5%)

⏱️ 1WK 분석

💰 현재가: $103.25

📊 거래량: 26,766,119

📈 RSI: 71.46

📉 MACD: 9.58

📌 예측:

• 3 기간 → Hold (신뢰도 57.67%)
• 5 기간 → Hold (신뢰도 56.95%)
• 10 기간 → Hold (신뢰도 57.68%)

⏱️ 1MO 분석

💰 현재가: $103.25

📊 거래량: 54,294,064

📈 RSI: 63.44

📉 MACD: 9.43

📌 예측:

• 3 기간 → Sell (신뢰도 50.79%)
• 5 기간 → Sell (신뢰도 49.38%)
• 10 기간 → Sell (신뢰도 50.2%)

✅ 최종 판단: Sell

📌 판단 근거: 매도 신호가 우세

💹 매수 점수: 5.00 | 매도 점수: 308.44